RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANT
Clinical trials for RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANT explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANT trials appear
Sign up with your email to follow new studies for RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single dose shield preemie lungs?
Prevention CompletedThis early-stage trial tested a new drug called rfhSP-D in 18 very premature babies (born before 30 weeks) to find the safest dose. The goal is to see if this drug can prevent chronic lung disease, a common complication in preemies. The study focused on safety and dosing, not yet…
Matched conditions: RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANT
Phase: PHASE1 • Sponsor: University College, London • Aim: Prevention
Last updated May 17, 2026 06:59 UTC
-
Tiny lungs, big comparison: which breathing support works best?
Knowledge-focused CompletedThis study looked at how extremely low birth weight babies (born before 29 weeks) responded to two types of breathing support: high-flow nasal cannula and nasal CPAP. Researchers measured lung function using a special imaging technique. The goal was to understand the differences,…
Matched conditions: RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANT
Phase: NA • Sponsor: Sharp HealthCare • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC